A. Ropo

发表

Increased anterior chamber penetration of topical levofloxacin 0.5% after pulsed dosing in cataract patients

U. Stenevi, D. Seal, K. Sundelin, 2009, Acta ophthalmologica.

A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost.

H. Uusitalo, M. Papadia, C. Traverso, 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients

M. Kähönen, T. Nieminen, V. Turjanmaa, 2005, European Journal of Clinical Pharmacology.

Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015 % and Timolol 0.5 % in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies

K. Kaarniranta, E. Mannermaa, A. Ropo, 2016, Clinical Pharmacokinetics.

Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open‐angle glaucoma and ocular hypertension: 24‐month results of a randomized, double‐masked phase III study

H. Uusitalo, L. Pillunat, A. Ropo, 2010, Acta ophthalmologica.

Adjunctive Use of Tafluprost with Timolol Provides Additive Effects for Reduction of Intraocular Pressure in Patients with Glaucoma

A. Ropo, E. Egorov, 2009, European journal of ophthalmology.

Pharmacokinetics, efficacy and safety profiles of preserved and preservative‐free tafluprost in healthy volunteers

H. Uusitalo, K. Kaarniranta, A. Ropo, 2008, Acta ophthalmologica. Supplement.

Efficacy and safety levels of preserved and preservative‐free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis

T. Hamacher, M. Liinamaa, V. Saarela, 2008, Acta ophthalmologica. Supplement.

A 6-Month Study Comparing Efficacy , Safety , and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0 . 0015 % and Timolol 0 . 5 % versus Each of Its Individual Preservative-Free Components

N. Pfeiffer, H. Uusitalo, J. Liinamaa, 2014 .

Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients.

G. Holló, A. Ropo, A. Hommer, 2014, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Switching from a preserved to a preservative‐free prostaglandin preparation in topical glaucoma medication

T. Hamacher, N. Pfeiffer, H. Uusitalo, 2009, Acta ophthalmologica.

Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

M. Kähönen, V. Turjanmaa, H. Uusitalo, 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.

M. Kähönen, V. Turjanmaa, K. Tahvanainen, 2005, Acta ophthalmologica Scandinavica.

Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study

M. Aihara, Naveed B K Shams, Fenghe Lu, 2020, Japanese Journal of Ophthalmology.

Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor.

H. Kautiainen, H. Vapaatalo, J. Uusitalo, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Handling test of eye drop dispenser--comparison of unit-dose pipettes with conventional eye drop bottles.

A. Ropo, M. Parkkari, T. Latvala, 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin.

J. Colin, A. Ropo, K. Geldsetzer, 2003, Acta ophthalmologica Scandinavica.

Corneal penetration of fluoroquinolones: Aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops

M. Roessler, A. Ropo, K. Geldsetzer, 2005, Journal of cataract and refractive surgery.

Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles

K. Kaarniranta, A. Ropo, 2018 .

Ptosis following periocular or general anaesthesia in cataract surgery

P. Ruusuvaara, A. Ropo, P. Nikki, 1992, Acta ophthalmologica.

A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males.

A. Ropo, A. Gilvarry, A. Sutton, 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study

T. Lehtimäki, M. Kähönen, T. Nieminen, 2005, European Journal of Clinical Pharmacology.

Orbicular muscle akinesia: a comparison, using electromyography, of three techniques.

A. Ropo, 1992, Ophthalmic surgery.

Effect of ocular compression (Autopressor®) on intraocular pressure in periocular anaesthesia

M. Paloheimo, E. Maunuksela, P. Ruusuvaara, 1990, Acta ophthalmologica.

Periocular anaesthesia: Technique, effectiveness and complications with special reference to postoperative ptosis

M. Paloheimo, E. Maunuksela, P. Ruusuvaara, 1990, Acta ophthalmologica.

Comparison of retrobulbar and periocular injections of lignocaine by computerised tomography.

L. Kivisaari, P. Ruusuvaara, A. Ropo, 1991, The British journal of ophthalmology.

Visual evoked potentials after retrobulbar or periocular anaesthesia.

K. Setälä, P. Ruusuvaara, A. Ropo, 1992, The British journal of ophthalmology.

Comparison of etidocaine and bupivacaine + lidocaine in retrobulbar anaesthesia.

K. Setälä, P. Ruusuvaara, A. Ropo, 2009, Acta ophthalmologica Scandinavica.

Ophthalmic timolol: Plasma concentration and systemic cardiopulmonary effects

T. Lehtimäki, M. Kähönen, T. Nieminen, 2007, Scandinavian journal of clinical and laboratory investigation.

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study

N. Pfeiffer, C. Erb, L. Pillunat, 2017, Clinical ophthalmology.

Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products

N. Pfeiffer, T. Huttunen, G. Holló, 2014, Advances in Therapy.

Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma

G. Holló, A. Ropo, 2015, Current medical research and opinion.

Cardiovascular effects of ophthalmic 0·5% timolol aqueous solution and 0·1% timolol hydrogel

M. Kähönen, V. Turjanmaa, T. Kuusela, 2002, Clinical physiology and functional imaging.

Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma.

T. Zimmerman, W. C. Stewart, R. Starita, 1996, American journal of ophthalmology.

Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study

K. Kaarniranta, K. Lorenz, C. Traverso, 2019, BMJ Open.

IOP lowering effect of omidenepag isopropyl in latanoprost non-/low-responder subjects with primary open-angle glaucoma or ocular hypertension: the FUJI study

M. Aihara, Naveed B K Shams, Fenghe Lu, 2018 .

A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis.

A. Ropo, P. Gous, 2004, Journal of Ocular Pharmacology and Therapeutics.

Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products.

N. Pfeiffer, T. Huttunen, G. Holló, 2014, Advances in therapy.

N. Pfeiffer, H. Uusitalo, J. Liinamaa, 2014 .

Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor.

H. Kautiainen, H. Vapaatalo, J. Uusitalo, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.